**Core Concept**
H. pylori (Helicobacter pylori) is a Gram-negative bacterium that primarily inhabits the gastric mucosa, leading to chronic gastritis, peptic ulcers, and an increased risk of gastric cancer. The bacterium's presence triggers a strong immune response, and its eradication is crucial for the treatment of H. pylori-related diseases.

**Why the Correct Answer is Right**
The bacterium's ability to colonize the gastric mucosa is attributed to its unique flagellar motility and the production of enzymes such as urease, which helps to neutralize the acidic environment of the stomach. H. pylori also produces adhesins, such as BabA and AlpA, which facilitate its attachment to gastric epithelial cells. The bacterium's colonization leads to chronic inflammation, which may progress to atrophic gastritis, intestinal metaplasia, and eventually gastric adenocarcinoma.

**Why Each Wrong Option is Incorrect**
**Option A:** H. pylori is not a viral pathogen. While it does stimulate a strong immune response, it is a bacterial infection, not a viral one.
**Option B:** H. pylori is not typically associated with the small intestine. Its primary habitat is the gastric mucosa, although it can occasionally be found in the duodenum.
**Option C:** H. pylori is not eradicated by antibiotics alone. While antibiotics are a crucial component of H. pylori treatment, they are typically used in combination with proton pump inhibitors (PPIs) or bismuth-based quadruple therapy to effectively eradicate the bacterium.

**Clinical Pearl / High-Yield Fact**
The "3-4-2 rule" is a useful mnemonic for H. pylori treatment: 3 days of triple therapy (2 antibiotics + 1 PPI) for 2 weeks, followed by a 4-week course of omeprazole or another PPI to prevent ulcer recurrence.

**Correct Answer: B. H. pylori is typically associated with the gastric mucosa, not the small intestine.**